KANDEROVA, Veronika, Tamara SVOBODOVA, Simon BORNA, Martina FEJTKOVA, Vendula MARTINU, Jana PADEROVA, Michael SVATON, Jarmila KRALOVA, Eva FRONKOVA, Adam KLOCPERK, Stepanka PRUHOVA, Min Ae LEE-KIRSCH, Ludmila HORNOFOVA, Miroslav KOBLIZEK, Petr NOVAK, Olga ZIMMERMANNOVA, Zuzana PARACKOVA, Anna SEDIVA, Tomas KALINA, Ales JANDA, Jana KAYSEROVA, Marcela DVORAKOVA, Milan MACEK, Petr POHUNEK, Petr SEDLACEK, Ashleigh POH, Matthias ERNST, Tomas BRDICKA, Ondrej HRUSAK and Jan LEBL. Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK. Journal of allergy and clinical immunology. New York: Mosby-Elsevier, 2022, vol. 149, No 4, p. 1464-1472, 12 pp. ISSN 0091-6749. Available from: https://dx.doi.org/10.1016/j.jaci.2021.07.046.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK
Authors KANDEROVA, Veronika, Tamara SVOBODOVA, Simon BORNA, Martina FEJTKOVA, Vendula MARTINU, Jana PADEROVA, Michael SVATON, Jarmila KRALOVA, Eva FRONKOVA, Adam KLOCPERK, Stepanka PRUHOVA, Min Ae LEE-KIRSCH, Ludmila HORNOFOVA, Miroslav KOBLIZEK, Petr NOVAK, Olga ZIMMERMANNOVA, Zuzana PARACKOVA, Anna SEDIVA, Tomas KALINA, Ales JANDA, Jana KAYSEROVA, Marcela DVORAKOVA, Milan MACEK, Petr POHUNEK, Petr SEDLACEK, Ashleigh POH, Matthias ERNST, Tomas BRDICKA, Ondrej HRUSAK and Jan LEBL.
Edition Journal of allergy and clinical immunology, New York, Mosby-Elsevier, 2022, 0091-6749.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 14.200
RIV identification code RIV/00216224:14740/22:00128769
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.jaci.2021.07.046
UT WoS 000820784100013
Keywords in English SRC-family kinase; hematopoietic cell kinase; inborn error of immunity; pulmonary hemorrhage; cutaneous vasculitis; autoinflammation; inflammatory cytokines; reactive oxygen species; ruxolitinib
Tags ne MU, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 5/4/2023 10:44.
Abstract
Background: Inborn errors of immunity are genetic disorders characterized by various degrees of immune dysregulation that can manifest as immune deficiency, autoimmunity, or autoinflammation. The routine use of next-generation sequencing in the clinic has facilitated the identification of an ever-increasing number of inborn errors of immunity, revealing the roles of immunologically important genes in human pathologies. However, despite this progress, treatment is still extremely challenging. Objective: We sought to report a new monogenic autoinflammatory disorder caused by a de novo activating mutation, p.Tyr515*, in hematopoietic cell kinase (HCK). The disease is characterized by cutaneous vasculitis and chronic pulmonary inflammation that progresses to fibrosis. Methods: Whole-exome sequencing, Sanger sequencing, mass spectrometry, and western blotting were performed to identify and characterize the pathogenic HCK mutation. Dysregulation of mutant HCK was confirmed ex vivo in primary cells and in vitro in transduced cell lines. Results: Mutant HCK lacking the C-terminal inhibitory tyrosine Tyr522 exhibited increased kinase activity and enhanced myeloid cell priming, migration and effector functions, such as production of the inflammatory cytokines IL-1 beta, IL-6, IL-8, and TNF-alpha, and production of reactive oxygen species. These aberrant functions were reflected by inflammatory leukocyte infiltration of the lungs and skin. Moreover, an overview of the clinical course of the disease, including therapies, provides evidence for the therapeutic efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in inflammatory lung disease. Conclusions: We propose HCK-driven pulmonary and cutaneous vasculitis as a novel autoinflammatory disorder of inborn errors of immunity.
Links
90127, large research infrastructuresName: CIISB II
PrintDisplayed: 12/7/2024 23:05